Evidence map›Paper›PMID 17874044›Full record

ReviewMedical molecular morphology2007

In situ production of sex steroids in human breast carcinoma.

Takashi Suzuki, Yasuhiro Miki, Takuya Moriya, Jun-Ichi Akahira, Hisashi Hirakawa, Noriaki Ohuchi, Hironobu Sasano

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical molecular morphology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Promiscuity and diversity in 3-ketosteroid reductases.The Journal of steroid biochemistry and molecular biology · 2015
    Review
  8. Endometriosis still a challenge.Journal of medicine and life · 2014
    Review
  9. Article
  10. Review
  11. Androgens in human breast carcinoma.Medical molecular morphology · 2010
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takashi SuzukiDepartment of Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. t-suzuki@patholo2.med.tohoku.ac.jp
Yasuhiro Miki
Takuya Moriya
Jun-Ichi Akahira
Hisashi Hirakawa
Noriaki Ohuchi
Hironobu Sasano
KKR Tohoku Kosai Hospital · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that sex steroids are closely involved in the growth of human breast carcinomas, and the great majority of breast carcinomas express sex steroid receptors. In particular, recent studies have demonstrated that estrogens and androgens are locally produced and act in breast carcinoma tissues without release into plasma. Blockade of intratumoral estrogen production potentially leads to an improvement in the prognosis of invasive breast carcinoma patients, and, therefore, it is important to obtain a better understanding of sex steroid-producing enzymes in breast carcinoma. In this review, we summarize recent studies on tissue concentration of sex steroids and expression of enzymes related to intratumoral production of estrogens [aromatase, steroid sulfatase (STS), and 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1)], and androgens (17betaHSD5 and 5alpha-reductase) in invasive and in situ (noninvasive) breast carcinomas, and discuss the significance of intratumoral production of sex steroids in breast carcinoma.

Indexed as

AndrogensBreastBreast NeoplasmsEstrogensFemaleGonadal Steroid HormonesHumansNeoplasm InvasivenessAndrogensEstrogensGonadal Steroid Hormones

Identifiers

PMID17874044
OpenAlexW2014321895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.